Twinbeech Capital LP Ideaya Biosciences, Inc. Transaction History

Twinbeech Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$14.5 - $22.63 $501,076 - $782,024	34,557 New	34,557 $726,000
Q4 2024 Feb 14, 2025	SELL	$24.79 - $31.98 $1.78 Million - $2.29 Million	-71,664 Reduced 44.94%	87,802 $2.26 Million
Q3 2024 Nov 14, 2024	BUY	$30.37 - $43.05 $3.26 Million - $4.62 Million	107,419 Added 206.39%	159,466 $5.05 Million
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $1.56 Million - $1.97 Million	-45,375 Reduced 46.58%	52,047 $1.83 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $3.33 Million - $4.59 Million	97,422 New	97,422 $4.27 Million

238

82.1M

509K

103K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.54B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.